These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8926500)

  • 41. Treatment with botulinum toxin improves the hyperexcitability of the facial motoneuron in patients with hemifacial spasm.
    Ishikawa M; Takashima K; Kamochi H; Kusaka G; Shinoda S; Watanabe E
    Neurol Res; 2010 Jul; 32(6):656-60. PubMed ID: 19660185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum toxin injection and tear production.
    Alsuhaibani AH; Eid SA
    Curr Opin Ophthalmol; 2018 Sep; 29(5):428-433. PubMed ID: 29994851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin paralysis of the orbicularis oculi muscle. Types and time course of alterations in muscle structure, physiology and lid kinematics.
    Horn AK; Porter JD; Evinger C
    Exp Brain Res; 1993; 96(1):39-53. PubMed ID: 8243582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The trigeminally evoked blink reflex. I. Neuronal circuits.
    Pellegrini JJ; Horn AK; Evinger C
    Exp Brain Res; 1995; 107(2):166-80. PubMed ID: 8773237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term follow-up of patients with frontalis sling operation in the treatment of essential blepharospasm unresponsive to botulinum toxin therapy.
    Wabbels B; Roggenkämper P
    Graefes Arch Clin Exp Ophthalmol; 2007 Jan; 245(1):45-50. PubMed ID: 16874524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trigeminal afferent input alters the excitability of facial motoneurons in hemifacial spasm.
    Ogawara K; Kuwabara S; Kamitsukasa I; Mizobuchi K; Misawa S; Hattori T
    Neurology; 2004 May; 62(10):1749-52. PubMed ID: 15159472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of photic conditioning on blink reflex recovery function in blepharospasm.
    Katayama M; Kohara N; Kaji R; Kojima Y; Shibasaki H; Kimura J
    Electroencephalogr Clin Neurophysiol; 1996 Oct; 101(5):446-52. PubMed ID: 8913199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patient-reported benefit from botulinum toxin treatment for essential blepharospasm: using 2 assessment scales.
    Lee RM; Chowdhury HR; Hyer JN; Smith HB; Jones CA
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):196-7. PubMed ID: 23446304
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinicophysiological studies of orbicularis oculi reflex in brain stem diseases].
    Goya T; Yoshida M; Matsukado Y; Shimizu H; Kano T
    No To Shinkei; 1976 Feb; 28(2):173-83. PubMed ID: 1036042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative assessment of botulinum toxin injection on blink rate in blepharospasm.
    Yazdanpanah G; Yen MT; Pflugfelder SC
    Orbit; 2023 Dec; 42(6):571-578. PubMed ID: 36484152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The 'geste antagonistique' induces transient modulation of the blink reflex in human patients with blepharospasm.
    Gómez-Wong E; Martí MJ; Cossu G; Fabregat N; Tolosa ES; Valls-Solé J
    Neurosci Lett; 1998 Jul; 251(2):125-8. PubMed ID: 9718990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bell's palsy-induced blepharospasm relieved by passive eyelid closure and responsive to apomorphine.
    Cattaneo L; Chierici E; Pavesi G
    Clin Neurophysiol; 2005 Oct; 116(10):2348-53. PubMed ID: 16098807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blink reflex studies in postparalytic facial syndrome and blepharospasm: trigeminal and extratrigeminal somatosensory stimulation.
    Benbir G; Kiziltan ME
    J Clin Neurophysiol; 2014 Dec; 31(6):535-40. PubMed ID: 25462139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of electrical stimulation as an adjunct to botulinum toxin type A in the treatment of adult spasticity: a systematic review.
    Intiso D; Santamato A; Di Rienzo F
    Disabil Rehabil; 2017 Oct; 39(21):2123-2133. PubMed ID: 27764971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sensory modulation of the blink reflex in patients with blepharospasm.
    Gómez-Wong E; Martí MJ; Tolosa E; Valls-Solé J
    Arch Neurol; 1998 Sep; 55(9):1233-7. PubMed ID: 9740118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The trigemino-facial reflex in patients with essential blepharospasm. A contribution to the etiology of the disease picture].
    Laskawi R; Damenz W; Roggenkämper P; Schröder M; Brauneis J
    Laryngorhinootologie; 1990 Jan; 69(1):45-7. PubMed ID: 2310460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disease progression in blepharospasm: a 5-year longitudinal study.
    Ferrazzano G; Conte A; Gigante A; Defazio G; Berardelli A; Fabbrini G
    Eur J Neurol; 2019 Feb; 26(2):268-273. PubMed ID: 30308706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm.
    Alderson K; Holds JB; Anderson RL
    Neurology; 1991 Nov; 41(11):1800-5. PubMed ID: 1944912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new variant of blepharospasm.
    Elston JS
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):369-71. PubMed ID: 1602309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
    Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
    J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.